Skip to content
healthcare.dev

Baqsimi

NDC 0548-8351, glucagon, powder, from Amphastar Pharmaceuticals, Inc..

Product NDC
0548-8351
Status
Listed
Labeler
Amphastar Pharmaceuticals, Inc.
Dosage form
POWDER
Route
NASAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210134
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0548-8351 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLUCAGON3 mg/1

Pharmacologic classes

Antihypoglycemic Agent [EPC]; Decreased GI Motility [PE]; Decreased GI Smooth Muscle Tone [PE]; Decreased Glycolysis [PE]; Gastrointestinal Motility Inhibitor [EPC]; Increased Gluconeogenesis [PE]; Increased Glycogenolysis [PE]

Package NDCNDC-11Package
0548-8351-01005488351011 TUBE in 1 CARTON (0548-8351-01) / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f1f5df9b-872f-44e5-a18f-f0b68e7e9254
  • NADAC price for package 00548835101

    GET /v1/drugs/nadac/00548835101

Use it

Look up 0548-8351 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0548-8351 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0548-8351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.